Dance Biopharm is a private company focused on developing novel inhaled formulations of medicines to treat diabetes and other serious chronic diseases. The company began operations in 2010, founded by Dr. John Patton, who has more than 28 years of experience developing inhaled insulin and other inhaled therapies. For more information, please visit www.dancebiopharm.com
Looking for a particular Dance Biopharm employee's phone or email?
The Dance Biopharm annual revenue was $13 million in 2026.
Gary Miller is the Associate Director, Quality Assurance of Dance Biopharm.
4 people are employed at Dance Biopharm.
Dance Biopharm is based in San Francisco, California.
The NAICS codes for Dance Biopharm are [541, 5417, 54].
The SIC codes for Dance Biopharm are [38, 384].